drugset
drugset / Trial / NCT03635879

Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides

NCT03635879 ↗

Phase 1 Withdrawn Cerecin
RandomizedCrossoverOpen-labelOther

Summary

This is a Phase I, open label, randomized, 6-way crossover, pilot PK study

Timeline

Start
2019-02-13
Primary completion
2019-04-16
Completion
2019-04-16

Outcome

Outcome not reported

Stopped: “Study redesign”

Drugs

EvaluationDrugModalityDoseRoute
Subject Tricaprilin Other / unclassified 20 g —

Indications

Alzheimer disease